13F Holdings
中文EN

WOK WORK Medical Technology Group LTD Annual reports only

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1929783 · Fiscal year ends 09/30

Financial factors as of 2025-09-30 (FY2025), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY-14.4%
TTM net income YoY69.3%
TTM EPS YoY85.2%
Revenue 3-yr CAGR-20.6%
Net income 3-yr CAGR—

Margins

Gross margin23.8%
Operating margin—
Net margin-10.9%
FCF margin49.9%
EBITDA margin—

Returns

ROE-6.8%
ROA-3.1%
ROIC (approx.)—
Asset turnover0.28x

Leverage & solvency

Liabilities / assets36.2%
Debt / equity0.00x
Current ratio1.71x
Interest coverage—

Cash quality & payout

Operating cash flow / net income-5.82x
Accruals ratio-21.1%
Payout ratio—
Capex / revenue13.5%

Factor history charts and full statement history on Pro 🔒

Financial statements

Annual Quarterly (none) Export CSV 🔒
Line item FY20252025-09-30FY20242024-09-30FY20232023-09-30FY20222022-09-30
Income statement
Revenue$9.85M$11.51M$13.57M$19.71M
Gross profit$2.34M$2.87M$4.14M$4.42M
R&D expense$435,311$302,511$301,644$183,900
SG&A expense$2.33M$4.56M$1.86M$2.56M
Interest expense$503,519$557,571$392,741$352,968
Pretax income-$1.08M-$3.67M$110,389$1.11M
Income tax$119,053-$125,291$47,006$169,435
Net income-$1.07M-$3.49M$112,030$865,210
EPS (basic)-0.04-0.270.010.07
EPS (diluted)-0.04-0.270.010.07
Weighted avg. shares (diluted)28.98M12.71M12.50M12.50M
Balance sheet
Cash & equivalents$4.09M$6.56M$1.60M$773,422
Receivables$615,838$1.65M$3.33M—
Inventory$2.46M$3.18M$4.62M—
Current assets$20.46M$20.83M$22.15M—
PP&E, net$10.59M$11.37M$6.63M—
Intangibles$959,116$1.04M$998,450—
Total assets$33.16M$36.25M$29.96M—
Current liabilities$11.97M$20.18M$18.92M—
Short-term debt$6.39M$13.32M$8.84M—
Total liabilities$11.99M$20.18M$18.97M—
Shareholders' equity$18.34M$13.19M$9.88M$11.19M
Shares outstanding—14.59M12.50M—
Cash flow statement
Operating cash flow$6.24M-$2.23M$2.21M-$2.26M
Capital expenditure$1.33M$9.23M$455,391$2.01M
Free cash flow$4.91M-$11.45M$1.75M-$4.27M
Investing cash flow-$7.61M-$9.06M-$583,304-$1.35M
Financing cash flow-$898,212$15.66M-$728,719$3.57M
Depreciation & amortization$923,108$1.41M$1.60M$3.26M

· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.